Group One Trading’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,900
Closed -$51.3K 8125
2025
Q4
$51.3K Sell
12,900
-300
-2% -$1.33K ﹤0.01% 5585
2025
Q3
$49.9K Buy
+13,200
New +$44.8K ﹤0.01% 5968
2022
Q4
Sell
-1,500
Closed -$6K 7628
2022
Q3
$6K Sell
1,500
-30,000
-95% -$228K ﹤0.01% 6746
2022
Q2
$356K Buy
31,500
+30,400
+2,764% +$364K ﹤0.01% 3736
2022
Q1
$18K Buy
+1,100
New +$28.2K ﹤0.01% 6818
2021
Q4
Sell
-100
Closed -$7K 8480
2021
Q3
$7K Sell
100
-700
-88% -$50.6K ﹤0.01% 7633
2021
Q2
$67K Buy
+800
New +$52.8K ﹤0.01% 6327

Other funds holding NBP

Group One Trading's NBP Position: Q2 2026 in Review

Group One Trading opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026: 143 shares worth $279. The stake represents ﹤0.01% of the portfolio and ranks #7357 among its holdings. This is a return to the name: Group One Trading previously reported a position in NBP as recently as Q4 2025.

Group One Trading first reported a position in NBP in Q2 2021 and has held it in 5 quarters since. The position peaked at $289K in Q2 2022. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • Group One Trading held 143 shares of NovaBridge Biosciences American Depositary Shares worth $279 as of Q2 2026.
  • NovaBridge Biosciences American Depositary Shares was a new Group One Trading position in Q2 2026.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7357 holding.
  • Group One Trading first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and has held it in 5 quarters since.
  • Group One Trading's NovaBridge Biosciences American Depositary Shares position peaked at $289K in Q2 2022.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.